Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingeng Lu

Showing results (21-30 of 206) with videos related to

Pageof 21
Sort By:
Cancer Cell International|November 24, 2022
Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitorRui Han, Hongxing Yang, Changquan Ling, et al.
Cancers|February 11, 2023
MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer TreatmentHuiling Zhou, Wentao Jia, Lingeng Lu, et al.
Journal of Food Protection|July 24, 2004
Autoinducer-2-like activity associated with foods and its interaction with food additivesLingeng Lu, Michael E Hume, Suresh D Pillai
Foodborne Pathogens and Disease|September 15, 2005
Autoinducer-2-like activity on vegetable produce and its potential involvement in bacterial biofilm formation on tomatoesLingeng Lu, Michael E Hume, Suresh D Pillai
Pancreas|September 8, 2020
Syndecan-1 and KRAS Gene Expression Signature Associates With Patient Survival in Pancreatic CancerYixing Wu, Huatian Huang, Beatrice Fervers, et al.
Annals of Neurology|February 3, 2024
The Melanocortin and Endorphin Neuropeptides in Patients with Restless Legs SyndromeBrian B Koo, Ahmed Abdelfattah, Athar Eysa, et al.
International Immunopharmacology|June 1, 2020
Factors affecting tumor responders and predictive biomarkers of toxicities in cancer patients treated with immune checkpoint inhibitorsLiqin Yao, Gang Jia, Lingeng Lu, et al.
Medical Oncology (Northwood, London, England)|September 29, 2022
Valeric acid acts as a novel HDAC3 inhibitor against prostate cancerRui Han, Hongxing Yang, Ya Li, et al.
Nucleic Acids Research|October 9, 2023
tRFtarget 2.0: expanding the targetome landscape of transfer RNA-derived fragmentsNingshan Li, Siqiong Yao, Guangjun Yu, et al.
Oral Oncology|December 31, 2019
Transfer RNA methyltransferase gene NSUN2 mRNA expression modifies the effect of T cell activation score on patient survival in head and neck squamous carcinomaLingeng Lu, Stephen G Gaffney, Vincent L Cannataro, et al.
Pageof 21

Showing results (21-30 of 206) with videos related to

Sort By:
Pageof 21
Cancer Cell International|November 24, 2022
Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitorRui Han, Hongxing Yang, Changquan Ling, et al.
Cancers|February 11, 2023
MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer TreatmentHuiling Zhou, Wentao Jia, Lingeng Lu, et al.
Journal of Food Protection|July 24, 2004
Autoinducer-2-like activity associated with foods and its interaction with food additivesLingeng Lu, Michael E Hume, Suresh D Pillai
Foodborne Pathogens and Disease|September 15, 2005
Autoinducer-2-like activity on vegetable produce and its potential involvement in bacterial biofilm formation on tomatoesLingeng Lu, Michael E Hume, Suresh D Pillai
Pancreas|September 8, 2020
Syndecan-1 and KRAS Gene Expression Signature Associates With Patient Survival in Pancreatic CancerYixing Wu, Huatian Huang, Beatrice Fervers, et al.
Annals of Neurology|February 3, 2024
The Melanocortin and Endorphin Neuropeptides in Patients with Restless Legs SyndromeBrian B Koo, Ahmed Abdelfattah, Athar Eysa, et al.
International Immunopharmacology|June 1, 2020
Factors affecting tumor responders and predictive biomarkers of toxicities in cancer patients treated with immune checkpoint inhibitorsLiqin Yao, Gang Jia, Lingeng Lu, et al.
Medical Oncology (Northwood, London, England)|September 29, 2022
Valeric acid acts as a novel HDAC3 inhibitor against prostate cancerRui Han, Hongxing Yang, Ya Li, et al.
Nucleic Acids Research|October 9, 2023
tRFtarget 2.0: expanding the targetome landscape of transfer RNA-derived fragmentsNingshan Li, Siqiong Yao, Guangjun Yu, et al.
Oral Oncology|December 31, 2019
Transfer RNA methyltransferase gene NSUN2 mRNA expression modifies the effect of T cell activation score on patient survival in head and neck squamous carcinomaLingeng Lu, Stephen G Gaffney, Vincent L Cannataro, et al.
Pageof 21